期刊文献+

5-氮杂-2'-脱氧胞苷对SW48结肠腺癌细胞生物学行为的影响 被引量:1

Effect of demethylating agent 5-Aza- 2'-deoxycytidine on human colonic carcinoma cell line SW48
下载PDF
导出
摘要 目的:研究去甲基化5-氮杂2'-脱氧胞苷(5-Aza-CdR)对SW48结肠腺癌细胞株生长周期及凋亡的影响,探讨其临床治疗的可能性.方法:分别使用浓度为0.4,1.6,6.4,25.6,102.4μmol/L特异型DNA甲基转移酶抑制剂5-Aza-CdR处理大肠腺癌细胞株.通过MTT来检测5-Aza-CdR对大肠癌细胞株存活率的影响.应用流式细胞检测甲基化5-Aza-CdR对SW48结肠腺癌细胞株生长周期及凋亡的影响.RT-PCR检测处理前后抑癌基因RASSF1AmRNA表达的改变.结果:5-氮杂2'-脱氧胞苷在1.6μmol/L就可以明显的抑制SW48结肠腺癌细胞的增殖,细胞周期中处于G0/G1期的细胞明显的增多,阻滞于G1期,凋亡率增高,而且以上作用与药物作用浓度,时间在一定范围内呈正相关.5-Aza-CdR处理后,无RASSF1A表达的SW48结肠腺癌细胞株可检测出基因RASSF1A的重新表达.结论:5-氮杂2'-脱氧胞苷可消除某些抑癌基因启动子甲基化状态,使其重新表达而抑制SW48结肠腺癌细胞株的生长,并促进其凋亡. AIM: To explore the effect of demethylating agent 5-Aza-2′-deoxycytidine (5-Aza-CdR) on the growth of human colonic carcinoma cell line SW48, and to investigate the possibility of its application in clinical treatment. METHODS: Human colonic carcinoma SW48 cells were treated with 0.4, 1,6, 6.4, 25.8, and 102.4 mol/L 5-Aza-CdR, respectively. Then the growth of the cells was observed by MTT assay. The cell cycle and apoptosis were analyzed by flow cytometry. The expression of the tumor suppressor gene RASSF1A mRNAwas detected by reverse transcription polymerase chain reaction (RT-PCR). RESULTS: 5-Aza-CdR inhibited the proliferation of SW48 cells in a time- and concentration-dependent manner (1-5 d, 0.4-102.4 mol/L). After 5-Aza-CdR treatment, the number of Go/G1 cells was increased, and 5-Aza-CdR blocked the cell cycle at G1 phase. The apoptotic rate was also increased significantly.RASSF1A gene was reactivated by 5-Aza-CdR in SW48 cells not expressing RASSF1A. CONCLUSION: 5-Aza-CdR can inhibit the growth, and promote the apoptosis of SW48 cells by eliminating the methylation status of RASSF1A promoter.
出处 《世界华人消化杂志》 CAS 北大核心 2005年第17期2094-2097,共4页 World Chinese Journal of Digestology
关键词 5-氮杂-2′-脱氧胞苷 SW48结肠腺癌细胞 细胞周期 细胞凋亡 5-Aza-2′-deoxycytidine SW48 cell lines Cell cycle Apoptosis
  • 相关文献

参考文献30

  • 1Zhang Y, Ng HH, Erdjument-Bromage H, Tempst P, Bird A, Reinberg D. Analysis of the NaRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes 1999; 13:1924-1935.
  • 2Prokhortchouk A, Hendrich B, Jorgensen H, Ruzoo A, Wilm M, Georgiev G, Bird A, Prokhortchouk E. The p120 catenin partner kaiso is a DNA methylation-dependent transcriptional repressor. Genes 2001;15:1613-1618.
  • 3Bird AP. The relationship of DNA methylation to cancer.Cancer Surv 1996;28:87-101.
  • 4Bird A. DNA methylation de novo. Science 1999;286:2287-2288.
  • 5Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP.Epigenetic inactivation of a RAS association domain family protein from the lung tumor suppressor locus 3p21.3. Nature Genet 2000;25:315-319.
  • 6Dammann R, Takahashi T, Pfeifer GP. The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas. Oncogeno 2001;20:3563-3567.
  • 7Bartlmg B, Hoffmann J, Holtz J, Schulz R, Heusch G, Darmer D.Quantification of cardioprotective gene expression in porcine short-term hibernating myocardium, J Mol Cell Cardiol 1999;31:147-158.
  • 8Burbee DG, Forgacs E, Zochbauer-Muller S, Shivakumar L, Fong K, Gao B, Randle D, Kondo M, Virmani A, Bader S,Sekido Y, Latif F, Milchgrub S, Toyooka S, Gazdar AF, Lerman MI, Zabarovsky E, White M, Minna JD. Epigenetic Inactivation of RASSFIA in Lung and Breast Cancers and Malignant Phenotype Suppression. J Natl Cancer Inst 2001;93:691-699.
  • 9Zochbauer MS,-Fung KM, Virmani AK ,Geradts J, Gazdar AF,Minna JD. Aberrant promoter methylation of multiple genes in nonsmall cell lung cancers. Cancer Res 2001;61:249-255.
  • 10Daskalakis M,Nguyen TT, Nguyen C, Guldberg P, Kohler G, Wijermans P, Jones PA, Lubbert M. Demethylation of a hypermethylated P15/INK4Bgene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatment. Blood 2002;100:2957-2964.

同被引文献13

  • 1Daskalakis M, Nguyen TT, Nguyen C, et al. Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastie syndrome by 5-Aza-2^+-deoxycytidine (decitabine) treatment. Blood, 2002, 100 (8): 2957-2964.
  • 2James R, Erler T, Kazenwadel J. Structure of the murine homeobox gene cdx-2. Expression in embryonic and adult intestinal epithelium. J Biol Chem, 1994, 269 (21): 15229-15237.
  • 3Lorentz O, Duluc I, Arcangelis AD, et al. Key role of the Cdx2 homeobox gene in extracellular matrix-mediated intestinal cell differentiation. J Cell Biol, 1997, 139 (6): 1553-1565.
  • 4Momparler RL. Cancer epigenetics. Oncogene, 2003, 22 (42): 6479-6483.
  • 5Turek-Plewa J, Jagodzihski PP. The role of mammalian DNA methyltransferases in the regulation of gene expression. Cell Mol Biol Lett, 2005, 10 (4): 631-647.
  • 6Brown R, Plumb JA. Demethylation of DNA by decitabine in cancer chemotherapy. Expert Rev Anticancer Ther, 2004, 4 (4): 501-510.
  • 7Esteller M. Relevance of DNA methylation in the management of cancer. Lancet Oncol, 2003, 4 (6): 351- 358.
  • 8Lyko F, Brown R. DNA methyltransferase inhibitors and the development of epigenetic cancer therapies. J Natl Cancer Inst, 2005, 97 (20): 1498-1506.
  • 9Nguyen CT, Weisenberger DJ, Velicescu M, et al. Histone H3-1ysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2'-deoxycytidine. Cancer Res, 2002, 62 (22): 6456-6461.
  • 10Drummond F, Putt W, Fox M, et al. Cloning and chromosome assignment of the human CDX2 gene. Ann Hum Genet, 1997, 61 (Pt 5): 393-400.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部